Langley J, Gold R
Department of Pediatrics, Faculty of Medicine, University of Toronto, Ontario, Canada.
Pediatr Infect Dis J. 1988 Jan;7(1):34-7. doi: 10.1097/00006454-198801000-00008.
Infection is the leading cause of death in children with cancer. A retrospective review of 100 episodes of sepsis in 80 children with cancer for a 21-month period showed that 74% of isolates were Gram-positive bacteria. Coagulase-negative staphylococci were the most common pathogens, accounting for 35% of all isolates. Initial empiric antibiotic therapy of fever in neutrogenic cancer patients was piperacillin and tobramycin. All but 12% of the Gram-negative isolates were susceptible to one or both of the antibiotics. However, 31% of the Gram-positive isolates were resistant to both antibiotics and 38% of the coagulase-negative staphylococci were methicillin-resistant. All of the latter were susceptible to vancomycin. The increasing incidence of coagulase-negative staphylococci as causes of sepsis in cancer patients suggests that the choice of antibiotics for initial empiric therapy may need to include vancomycin or an antistaphylococcal penicillin depending on the local incidence of methicillin resistance.
感染是癌症患儿的主要死因。一项对80名癌症患儿在21个月内发生的100例败血症进行的回顾性研究表明,74%的分离株为革兰氏阳性菌。凝固酶阴性葡萄球菌是最常见的病原体,占所有分离株的35%。中性粒细胞减少的癌症患者发热的初始经验性抗生素治疗为哌拉西林和妥布霉素。除12%的革兰氏阴性分离株外,所有分离株对其中一种或两种抗生素敏感。然而,31%的革兰氏阳性分离株对两种抗生素均耐药,38%的凝固酶阴性葡萄球菌对甲氧西林耐药。所有后者对万古霉素敏感。凝固酶阴性葡萄球菌作为癌症患者败血症病因的发病率不断上升,这表明初始经验性治疗的抗生素选择可能需要根据甲氧西林耐药的当地发病率,包括万古霉素或抗葡萄球菌青霉素。